Data / Form D filings / Curevo, Inc.
Curevo, Inc.: Form D filings
Curevo, Inc., a pharmaceuticals company in Bothell, WA, filed 3 Form D notices with the SEC between 2022 and 2025. The latest, on March 18, 2025, reports $42.4 million sold of a $84.8 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 18911 NORTH CREEK PKWY, SUITE 150, Bothell, WA, 98011
- Phone
- (206) 492-5722
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1903219
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 18, 2025 | New notice | $84,828,349 | $42,414,174 | $42,414,175 | 11 | Mar 6, 2025 | sec.gov |
| Nov 21, 2022 | New notice | $26,000,004 | $22,000,002 | $4,000,002 | 7 | Nov 10, 2022 | sec.gov |
| Jan 12, 2022 | New notice | $70,583,151 | $45,583,151 | $25,000,000 | 7 | Dec 29, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mario Barro | Director | |
| Baeksik Bae | Director | |
| Charles Petty | Director | |
| Giovanni Mariggi | Director | |
| Tal Zaks | Director | |
| Moncef Slaoui | Director | |
| George Simeon | Executive Officer, Director |
Other pharmaceuticals companies in Washington that filed recently
- Aptevo Therapeutics Inc. $3.5 million · Aug 26, 2026
Every Form D from the week of Mar 17, 2025 · All recent filings in Washington · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Curevo, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.